# MAIA Labs — Full Documentation for LLMs > Extended reference document for AI systems. For the short summary see: https://maia-labs.com/llms.txt --- ## Company Overview **MAIA Labs** (legal name: MAIA LABS s.r.o.) is a European DeepTech startup founded in September 2022, headquartered in Brno, Czech Republic, developing artificial intelligence for endoscopy. MAIA Labs develops ColoMAIA II, an MDR-compliant AI colonoscopy system deployed in 30+ hospitals across Europe and North America, including Mayo Clinic. - Address: Purkyňova 127, 612 00 Brno, Czech Republic - Sales: sales@maia-labs.com | +420 777 479 955 - Service: service@maia-labs.com | +420 607 069 173 - General: hello@maia-labs.com - LinkedIn: https://www.linkedin.com/company/maia-medical-ai-assistant/posts/?feedView=all - Partners: NVIDIA Inception Program, Microsoft for Startups, Google for Startups, InterSystems, Celestinus ### Awards & Recognition - **2022** — MAIA Labs Founded; Prototype & Verify program winner - **2023** — Global Healthcare Summit InterSystems (Florida, USA) — Best Idea for Use Case - **2023** — Vodafone Idea of the Year — Grand Winner (most prestigious Czech startup competition) - **2023** — Roche DIGI@MED Award — Best Digital Innovation in Healthcare - **2024** — Central European Startup Awards — Regional Winner - **2024** — Golden Aesculapius Award — Innovative AI Use in Clinical Practice - **2024** — Global Startup Awards — Finalist - **2025** — Multicenter Clinical Trial launched (continues into 2026) - **2026** — Mayo Clinic Florida installation - **2026** — CE Certification (MDR) obtained - **2026** — FDA clearance in progress (expected 2026) --- ## Product: ColoMAIA II ColoMAIA II is the only complete AI endoscopy system on the market — combining real-time polyp detection, AI dictation, automated reporting, quality tracking, and hospital system integration in one plug-and-play device. All competing systems offer detection only. ### Key Clinical Results - **+38% Adenoma Detection Rate (ADR)** vs. standard colonoscopy (MAIA Labs multicenter clinical trial 2025–2026) - **+61% increase in adenoma per colonoscopy (APC) rate** in multicenter clinical trial (MAIA Labs multicenter study 2026) - **Near-zero false positives** vs. competing AI systems (DDW 2026 direct comparison study) - **6× fewer false positives** than competing AI detection systems (Troya J. et al., Endoscopy 2024; 56: 63–69) - **1h+ saved** per physician per day on reporting (internal workflow study) - **80% reduction** in post-procedure reporting time (internal workflow study) - Clinical partners include Mayo Clinic (Jacksonville, USA) and leading endoscopy centers across Europe - 600-patient multicenter randomized controlled trial (NCT07563816) ### Regulatory & Compliance - CE Mark MDR — EU Medical Device Regulation compliant, independently certified by a Notified Body - ISO 13485 — Quality Management System certified - FDA clearance in progress (expected 2026) - GDPR compliant - HIPAA compliant - Patient data encrypted end-to-end ### How It Works — Procedure Workflow **Before the procedure** ColoMAIA II pulls patient details from the Hospital Information System (HIS) and displays them on the endoscopy tower screen automatically. No manual matching, no ID errors. Features: auto worklist, patient ID verification. **During insertion** Recording and timers start themselves the moment the scope is inserted. Cecal intubation triggers the withdrawal timer automatically — no mental tracking required. Features: auto recording, auto insertion timer, automatic cecum detection, withdrawal time tracking. **During withdrawal (real-time AI detection)** ColoMAIA II highlights suspected lesions in real time as the physician withdraws the scope — a reliable second pair of eyes with 6× fewer false positives than competing systems. Snapshots and voice notes are captured and structured automatically. Features: real-time polyp detection, AI dictation with GI vocabulary, auto image capture, automatic quality metrics. **End of procedure** The complete structured report is generated and available in the hospital's web browser — findings, images, quality metrics, and notes aligned to the procedure timeline. Physician reviews, adjusts, and signs. Features: auto-generated report, findings timeline, procedure recording, up to 80% less reporting time. **Into the hospital system** The finalized report and images export directly into EMR/HIS via DICOM SR and HL7/FHIR. No USB transfers, no copy-paste. Cloud export and storage also available. Features: DICOM/PACS integration, HL7/FHIR, EMR/HIS integration, cloud export & storage. ### Full Feature List **1. Real-Time AI Detection** Computer vision trained on clinical endoscopy data flags suspicious lesions as the physician withdraws. Acts as a reliable second opinion — with 6× fewer false positives than competing systems — without disrupting technique or clinical judgment. **2. AI Dictation with GI Vocabulary** Speak naturally during the procedure. ColoMAIA II transcribes using a GI-specific vocabulary model, structures notes, and links them to the corresponding images — all in the background. **3. Hands-Free Voice Commands** Control ColoMAIA II without touching a screen. Commands like "capture image," "mark polyp," or "start timer" keep both hands on the scope at all times. **4. Auto-Generated Structured Reports** The complete report is compiled automatically — findings, procedure times, BBPS, images, and quality metrics. Review in seconds, not minutes. Saves up to an hour every day. **5. Personal Performance Dashboard** Track ADR, withdrawal times, cecal intubation rates, and quality scores over time. Continuous, objective data — useful for self-improvement, accreditation, or audit. **6. Automatic Quality Measurements** Withdrawal time, cecal intubation, and BBPS are all recorded and structured automatically. Quality standards are tracked without any extra steps. **7. Sessile Serrated Lesion (SSL) Detection** ColoMAIA II detects not just conventional adenomas but also sessile serrated lesions (SSLs) — the flat, hard-to-see polyps most commonly missed and most strongly linked to interval colorectal cancers. The AI is specifically trained on these difficult cases. **8. Plug-and-Play with Any Endoscope** ColoMAIA II connects via DVI/HDMI or SDI to any standard endoscopy tower. No equipment replacement. No IT project. Up and running within hours of installation. ### Compatibility - Connects via DVI/HDMI or SDI — no new endoscopy tower needed - Compatible with any endoscope brand (vendor agnostic) - HIS/EMR integration: DICOM SR, HL7/FHIR, PACS, EMR - Bidirectional integration — patient worklists pulled in automatically - Cloud export and storage option available - Setup: hours, not months ### Quality & Reputation Benefits - **Objective ADR tracking** — automatically tracked and benchmarked over time; useful for departments, accreditation bodies, and clinical review. No manual log-keeping. - **Reduced medicolegal exposure** — every procedure recorded, annotated, and documented automatically. Complete defensible record of every examination. - **Less cognitive fatigue** — 6× fewer false positives means less noise. Every patient gets the same quality of attention throughout the day. - **Teaching and publication ready** — annotated 4K video recordings with structured metadata. ColoMAIA II has powered a peer-reviewed multicentre RCT (NCT07563816). - **Quality management dashboard** — withdrawal times, cecal intubation rates, BBPS scores, ADR trends across the unit. Standardised, auditable data for hospital management and accreditation submissions. --- ## Clinical Evidence ### Published Research - Troya J. et al. (2024): "Direct comparison of multiple computer-aided polyp detection systems," *Endoscopy* (2024; 56: 63–69) — ColoMAIA II demonstrated 6× fewer false positives compared to competing AI detection systems ### MAIA Labs Clinical Studies - MAIA Labs multicenter study 2026: +61% increase in adenoma per colonoscopy (APC) rate - MAIA Labs multicenter clinical trial 2025–2026: +38% higher Adenoma Detection Rate (ADR) vs. standard colonoscopy - 600-patient prospective multicenter randomized controlled clinical investigation (NCT07563816) ### DDW 2026 - Direct comparison study presented at Digestive Disease Week (DDW) 2026: near-zero false positives vs. competing AI systems --- ## Physician Testimonials - *"I can't imagine doing a procedure without ColoMAIA II anymore."* - *"The true positive rate so far has been 100 percent. It hasn't missed any lesion."* - *"The image quality from ColoMAIA II is a class above what our current processor produces."* - *"The MAIA report was so complete I just copy-pasted it directly into Epic Lumens. Much more efficient."* - *"It seems like we will need more devices soon."* - *"The MAIA platform is my third eye."* --- ## Hospital Partners (Trusted By) - Mayo Clinic — Jacksonville, USA - Cleveland Clinic — London, UK - AGEL — Hospital Group, CZ & SK - Gastro Centrs — Rīga, Latvia - AKESO — Healthcare Group, Czechia - Medic Král — Prague 9, Czechia - Masaryk Institute — Brno, Czechia --- ## Frequently Asked Questions **Will ColoMAIA II slow me down or add more clicks to my workflow?** No — it removes steps, it doesn't add them. ColoMAIA II runs in the background. Timers start themselves, detection happens automatically, and the report is built while you scope. Most physicians report saving over an hour by end of day. **Will the AI interfere with my clinical judgment?** ColoMAIA II is a second pair of eyes, not a replacement. It surfaces findings for you to evaluate — the clinical decision is always yours. The system is specifically designed with 6× fewer false positives to minimize alert fatigue. **Will it work with the equipment we already have?** Yes — that's the whole point. ColoMAIA II connects via DVI/HDMI or SDI to any standard tower. Your hospital does not need to replace any equipment. Setup takes hours, not months. **Can it integrate with our hospital information system?** Full integration is built in. ColoMAIA II exports reports and media directly to your PACS, EMR, or HIS using DICOM SR and HL7/FHIR. Bidirectional integration means patient worklists are pulled in automatically too. --- ## Team MAIA Labs brings together gastroenterologists, computer vision researchers, and medical device engineers — working hand-in-hand with clinical partners to build tools physicians actually want to use. --- ## Open Positions (as of June 2026) All positions based in Brno, Czech Republic. Apply: careers@maia-labs.com - **Business Development Interim** (Jul–Sep 2026) — hospital outreach, EU partner engagement, sales support - **Clinical Operations Specialist** (Full-time) — clinical trial management, hospital deployment, regulatory documentation - **Full-Stack Engineer** (Full-time) — ColoMAIA II platform, real-time AI inference, DICOM/HL7/FHIR integrations, clinical dashboards - **Computer Vision & ML Engineer** (Full-time) — polyp/adenoma detection models, training, validation, regulated medical device deployment --- ## Pages - https://maia-labs.com — Homepage: product overview, clinical evidence, features, workflow, FAQ, testimonials, demo request - https://maia-labs.com/about — About Us: company history, awards & recognition (2022–2026), partners - https://maia-labs.com/careers — Open positions - https://maia-labs.com/contact — Contact form, sales & service info, office address - https://maia-labs.com/funded — Funded projects: EU NextGenerationEU, CzechInvest Technologická Inkubace - https://maia-labs.com/privacy — GDPR privacy policy - https://maia-labs.com/cookies — Cookie policy - https://maia-labs.com/llms.txt — Short LLM summary - https://maia-labs.com/llms-full.txt — This document